NCT04855942

Brief Summary

Trigger finger is the common name of stenosing tenosynovitis of fingers, caused by repetitive trauma. Conservative treatment includes NSAIDs or other analgesic agents, activity modification, splint, and physiotherapy. Operation could be considered if conservative treatments fails. With literature reviewed, there is no treatment which is both non-invasive and effective, and also could avoid recurrence well. Extracorporeal shock wave therapy could induce angiogenesis, anti-inflammatory reaction, and recruitment of fibroblast. Although extracorporeal shock wave has been utilized in musculoskeletal diseases for more than twenty years, there is no well-designed clinical trial to prove the effectiveness of extracorporeal shock wave in treating trigger finger. The purpose of this study is to compare the effectiveness of extracorporeal shock wave therapy with traditional physical therapy for the management of trigger finger.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2021

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 10, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 22, 2021

Completed
9 days until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2022

Completed
Last Updated

July 25, 2022

Status Verified

July 1, 2022

Enrollment Period

8 months

First QC Date

March 10, 2021

Last Update Submit

July 21, 2022

Conditions

Keywords

extracorporeal shock wavetrigger fingerstenosing tenosynovitis

Outcome Measures

Primary Outcomes (5)

  • Quinnell stages of triggering

    Quinnell stages of triggering classifies the trigger finger using five types during flexion and extension: normal movement (Type 0), uneven movement (Type I), actively correctable (Type II), passively correctable (Type III) and fixed deformity (Type IV).

    15 weeks

  • 11-point numeric scale of pain

    The 11-point numeric scale of pain requires the patient to rate their pain on a defined scale. 0 is no pain and 10 is the worst pain imaginable.

    15 weeks

  • Chinese quick DASH (disabilities of the Arm, Shoulder, and Hand questionnaire)

    This questionnaire is a self-administered region-specific outcome instrument developed as a measure of self-rated upper-extremity disability and symptoms. The investigators chose the first two components: the disability and symptom section (11 items, scored 1-5). The lower score means better condition of upper limbs, and vice versa.

    15 weeks

  • strength of hand grip

    The strength of hand grip is to measure the maximum isometric strength of the hand and forearm muscles by a electicial grip strength device.

    15 weeks

  • sonographic image

    The investigators would record the characteristics of acquired sonographic images, such like the thickness of finger flexor tendon and A1 pulley, the presence of tendon sheath effusion, and the presence of increased vascularity by Doppler images.

    15 weeks

Study Arms (2)

Focused Extracorporeal Shock Wave Therapy (ESWT)

EXPERIMENTAL

2000 impulses of 5 Hz and 0.32 mJ/mm2 , twice per week for 3 weeks

Device: Focused Extracorporeal Shock Wave Therapy (ESWT)

Physiotherapy

ACTIVE COMPARATOR

therapeutic ultrasound, 12 times in 3 weeks

Device: physiotherapy

Interventions

2000 impulses of 5 Hz and 0.32 mJ/mm2 , twice per week for 3 weeks

Focused Extracorporeal Shock Wave Therapy (ESWT)

therapeutic ultrasound, 12 times in 3 weeks

Physiotherapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Quinnel classification grade 2 or 3
  • who has only one trigger

You may not qualify if:

  • who had ever treated the trigger finger
  • who has other musculoskeletal disease of the upper limb
  • who has severe coagulopathy disease
  • who is pregnant
  • who has arrhythmia or has a pacemaker
  • there is sensory impairment, scar, edema at the trigger finger
  • who has cognitive dysfunction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Trigger Finger DisorderTendon Entrapment

Interventions

Extracorporeal Shockwave TherapyPhysical Therapy Modalities

Condition Hierarchy (Ancestors)

TendinopathyMuscular DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsRehabilitation
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Our study design is mainly to compare the therapeutic effect to trigger finger between extracorporeal shock wave (PiezoWave2 ECO, produced by Richard Wolf) and traditional physiotherapy.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2021

First Posted

April 22, 2021

Study Start

May 1, 2021

Primary Completion

December 31, 2021

Study Completion

August 31, 2022

Last Updated

July 25, 2022

Record last verified: 2022-07